modelMeloxicamCombinations

Diagram of MeloxicamCombinations

Extends from Pharmacolibrary.Drugs.ATC.M.M01AC56.

Information

name:MeloxicamCombinations
ATC code:M01AC56
route:oral
compartments:2
dosage:15mg
volume of distribution:10L
clearance:0.42L/h
other parameters in model implementation

Meloxicam, in combination with other substances, is a non-steroidal anti-inflammatory drug (NSAID) belonging to the oxicam class, used primarily for its analgesic and anti-inflammatory effects in conditions such as osteoarthritis and rheumatoid arthritis. Meloxicam and its combinations are used in humans and some veterinary preparations. Meloxicam is approved for use in numerous countries.

Pharmacokinetics

Pharmacokinetic parameters for meloxicam, combinations, estimated for healthy adult individuals (sex not specified), typical oral administration.

References

  1. Naidoo, V, et al., & Swan, GE (2008). The pharmacokinetics of meloxicam in vultures. Journal of veterinary pharmacology and therapeutics 31(2) 128–134. DOI:10.1111/j.1365-2885.2007.00923.x PUBMED:https://pubmed.ncbi.nlm.nih.gov/18307504

  2. Mzyk, DA, et al., & Smith, GW (2023). Milk residues following multiple doses of meloxicam and gabapentin in lactating dairy cattle. Journal of the American Veterinary Medical Association 261(12) 1873–1879. DOI:10.2460/javma.23.06.0329 PUBMED:https://pubmed.ncbi.nlm.nih.gov/37734723

Parameters

TypeNameDefaultDescription
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.9Volume of distribution (L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)0.8bioavailiability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)20clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1000administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Pharmacolibrary.Types.VolumeVdp (from PK_2C)VdpPerKg*weightVolume of distribution (m3)
Modelica.Units.SI.SpecificVolumeVdpPerKg (from PK_2C)0.9Volume of distribution peripheral(l/kg)
Pharmacolibrary.Types.Clearancek12 (from PK_2C)1intercompartmental C-P clearance
Pharmacolibrary.Types.Clearancek21 (from PK_2C)1intercompartmental P-C clearance
Pharmacolibrary.Types.TransferRateka (from PK_2C_enteral)0.016666666666666666first order absorption rate
Modelica.Units.SI.TimeTlag (from PK_2C_enteral)600delay between oral administration and absorption (default 10min)

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)
Interfaces.ConcentrationPort_bperipheralCPort (from PK_2C)
Pharmacolibrary.Types.ConcentrationOutputC_peripheral1 (from PK_2C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)elimination half-life
Pharmacolibrary.Pharmacokinetic.TransferFirstOrderNonSymtransfer (from PK_2C)
Pharmacolibrary.Pharmacokinetic.NoPerfusedTissueCompartmentperipheral (from PK_2C)

Revisions

  • 06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)